---
title: "On November 3rd, LIVZON PHARMA spent CNY 5.9969 million to repurchase 164,000 A shares"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/263981801.md"
description: "According to the Zhitong Finance APP, LIVZON PHARMA announced that on November 3, 2025, the company spent RMB 5.9969 million to repurchase 164,000 A shares, with a repurchase price ranging from RMB 36.34 to RMB 36.70 per share"
datetime: "2025-11-03T09:50:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263981801.md)
  - [en](https://longbridge.com/en/news/263981801.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263981801.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/263981801.md) | [繁體中文](https://longbridge.com/zh-HK/news/263981801.md)


# On November 3rd, LIVZON PHARMA spent CNY 5.9969 million to repurchase 164,000 A shares

According to the Zhitong Finance APP, LIVZON PHARMA (01513) announced that on November 3, 2025, the company spent RMB 5.9969 million to repurchase 164,000 A-shares, with a repurchase price of RMB 36.34-36.70 per share

### 相关股票

- [LIVZON GROUP (000513.CN)](https://longbridge.com/zh-CN/quote/000513.CN.md)
- [LIVZON PHARMA (01513.HK)](https://longbridge.com/zh-CN/quote/01513.HK.md)

## 相关资讯与研究

- [China e-Wallet Payment to Be Delisted on March 16](https://longbridge.com/zh-CN/news/278322026.md)
- [Standard Chartered Advances Buy-back, Cancels More Shares to Lift Capital Efficiency](https://longbridge.com/zh-CN/news/278843914.md)
- [Rotork plc Non-GAAP EPS of 16.90p, revenue of £777.3M](https://longbridge.com/zh-CN/news/278515607.md)
- [Fosun Pharma Unit Gets China Nod for Hematological Malignancy Drug Trial](https://longbridge.com/zh-CN/news/279052280.md)
- [Standard Chartered bought back total 916,173 shares for GBP15.5 mln on other exchanges on Mar 10, HKEX filing shows](https://longbridge.com/zh-CN/news/278705553.md)